The administration of psilocybin to healthy, hallucinogen-experienced volunteers in a mock-functional magnetic resonance imaging environment: a preliminary investigation of tolerabilityCARHART-HARRIS, Robin L; WILLIAMS, Tim M; SESSA, Ben et al.Journal of psychopharmacology (Oxford). 2011, Vol 25, Num 11, pp 1562-1567, issn 0269-8811, 6 p.Article

LES HALLUCINOGENES: LEURS EFFETS1972; REV. MED.; FR.; DA. 1972; VOL. 13; NO 31; PP. 2057-2060 (3P.); BIBL. 7REF.Serial Issue

PSYCHOPHYSICS OF PSILOCYBIN AND DELTA ⁹-TETRAHYDROCANNABINOL = PSYCHOPHYSIQUE DE LA PSILOCYBINE ET DU DELTA ⁹-TETRAHYDROCANNABINOLSHAFFER JH; HILL RM; FISCHER R et al.1973; AGENTS AND ACTIONS; SWITZ.; DA. 1973; VOL. 3; NO 1; PP. 48-51; BIBL. 14 REF.Serial Issue

LYSERGIC ACID DIETHYLAMIDE (LSD) AS A DISCRIMINATIVE CUE: DRUGS WITH SIMILAR STIMULUS PROPERTIES = LE LYSERGAMIDE (LSD) EN TANT QUE SIGNE DE DISCRIMINATION: SUBSTANCES CHIMIQUES A PROPRIETES DE STIMULUS SIMILAIRESSCHECHTER MD; ROSECRANS JA.1972; PSYCHOPHARMACOLOGIA; ALLEM.; DA. 1972; VOL. 26; NO 3; PP. 313-316; BIBL. 14REF.Serial Issue

THE PSILOCYBIN MUSHROOM PANDEMIC.POLLOCK SH.1975; J. PSYCHED. DRUGS; U.S.A.; DA. 1975; VOL. 7; NO 1; PP. 73-84; BIBL. 2 P. 1/2Article

MOLECULAR STRUCTURES OF HALLUCINOGENIC SUBSTANCES: LYSERGIC ACID DIETHYLAMIDE, PSILOCYBIN, AND 2,4,5-TRIMETHOXYAMPHETAMINE = STRUCTURES MOLECULAIRES DES SUBSTANCES HALLUCINOGENES: DIETHYLAMIDE DE L'ACIDE LYSERGIQUE, PSILOCYBINE ET TRIMETHOXY-2,4,5 AMPHETAMINEBAKER RW; CHOTHIA C; PAULING P et al.1973; MOLEC. PHARMACOL.; U.S.A.; DA. 1973; VOL. 9; NO 1; PP. 23-32; BIBL. 23REF.Serial Issue

THE OCCURRENCE OF PSILOCYBIN IN GYMNOPILUS SPECIES.HATFIELD GM; VALDES LJ; SMITH AH et al.1978; LLOYDIA; E.U.; DA. 1978; VOL. 41; NO 2; PP. 140-144; BIBL. 20 REF.Article

DETECTION OF PSILOCYBIN IN SPECIES OF PSILOCYBE, PANAEOLUS AND PSATHYRELLA.OTT J; GUZMAN G.1976; LLOYDIA; E.U.; DA. 1976; VOL. 39; NO 4; PP. 258-260; BIBL. 17 REF.Article

The entheomycological origin of Egyptian crowns and the esoteric underpinnings of Egyptian religionBERLANT, Stephen R.Journal of ethnopharmacology. 2005, Vol 102, Num 2, pp 275-288, issn 0378-8741, 14 p.Article

Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of opennessMACLEAN, Katherine A; JOHNSON, Matthew W; GRIFFITHS, Roland R et al.Journal of psychopharmacology (Oxford). 2011, Vol 25, Num 11, pp 1453-1461, issn 0269-8811, 9 p.Article

Determination of psilocin and psilocybin using flow injection analysis with acidic potassium permanganate and tris(2,2'-bipyridyl) ruthenium(II) chemiluminescence detection respectivelyANASTOS, Nicole; BARNETT, Neil W; LEWIS, Simon W et al.Talanta (Oxford). 2005, Vol 67, Num 2, pp 354-359, issn 0039-9140, 6 p.Article

A systems model of altered consciousness: Integrating natural and drug-induced psychosesVOLLENWEIDER, Franz X; GEYER, Mark A.Brain research bulletin. 2001, Vol 56, Num 5, pp 495-507, issn 0361-9230Article

A COMPARISON OF PSYCHOTOMIMETIC DRUG EFFECTS ON RAT BRAIN NOREPINEPHRINE METABOLISM = COMPARAISON DES EFFETS DES MEDICAMENTS PSYCHOTOMIMETIQUES SUR LE METABOLISME DE LA NORADRENALINE DU CERVEAU DU RATSTOLK JM; BARCHAS JD; GOLDSTEIN M et al.1974; J. PHARMACOL. EXPER. THERAPEUT.; U.S.A.; DA. 1974; VOL. 189; NO 1; PP. 42-50; BIBL. 1P.Article

PHYSOSTIGMINE REVERSAL OF PSILOCYBIN INTOXICATIONVAN POORTEN JF; STIENSTRA R; DWORACEK B et al.1982; ANESTHESIOLOGY; ISSN 0003-3022; USA; DA. 1982; VOL. 56; NO 4; PP. 313; BIBL. 6 REF.Article

TREATMENT OF ACUTE HALLUCINOGENIC DRUG TOXICITY: SPECIFIC PHARMACOLOGICAL INTERVENTION = TRAITEMENT DE LA TOXICITE AIGUE DES HALLUCINOGENES: INTERVENTION PHARMACOLOGIQUE SPECIFIQUECONSROE PF.1973; AM. J. HOSP. PHARM.; U.S.A.; DA. 1973; VOL. 30; NO 1; PP. 80-84; BIBL. 1P.1/2Serial Issue

Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin = Questionnaire de l'analyse factorielle de l'expérience mystique : une étude de l'expérience occasionnée par la psilocybine hallucinogèneMACLEAN, Katherine A; JOHNSON, Matthew W; LEOUTSAKOS, Jeannie-Marie S et al.Journal for the scientific study of religion. 2012, Vol 51, Num 4, pp 721-737, issn 0021-8294, 17 p.Article

COMPARISON OF THE DISCRIMINATIVE STIMULUS PROPERTIES OF DELTA ⁹-THC AND PSILOCYBIN IN RATS = COMPARAISON DES PROPRIETES DE STIMULUS DISCRIMINATIF DU DELTA ⁹-THC ET DE LA PSILOCYBINE CHEZ DES RATSGREENBERG I; KUHN D; APPEL JB et al.1975; PHARMACOL. BIOCHEM. BEHAV.; U.S.A.; DA. 1975; VOL. 3; NO 5; PP. 931-934; BIBL. 19 REF.Article

DES CHAMPIGNONS HALLUCINOGENES EN BRETAGNEGERAULT A.1973; PENN. AR BED; FR.; DA. 1973; VOL. 9; NO 72; PP. 25-29; BIBL. 5 REF.Serial Issue

Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in miceHALBERSTADT, Adam L; KOEDOOD, Liselore; POWELL, Susan B et al.Journal of psychopharmacology (Oxford). 2011, Vol 25, Num 11, pp 1548-1561, issn 0269-8811, 14 p.Article

PSILOCYBIN NEUROPSYCHOPHARMACOLOGY IN RABBITSGUEST J; CONSROE P.1979; RES. COMMUNIC. PSYCHOL. PSYCHIATRY BEHAV.; USA; DA. 1979; VOL. 4; NO 1; PP. 93-96; BIBL. 9 REF.Article

CRYSTAL STRUCTURES OF THE TEONANACATL HALLUCINOGENS. I. PSILOCYBIN C₁₂H₁₇N₂O₄PWEBER HP; PETCHER TJ.1974; J. CHEM. SOC., PERKIN TRANS., 2; G.B.; DA. 1974; NO 8; PP. 942-946; BIBL. 11REF.Article

II. THE EFFECTS OF SOME HALLUCINOGENS ON AGGRESSIVENESS OF MICE AND RATSKOSTOWSKI W; REWERSKI W; PIECHOCKI T et al.1972; PHARMACOLOGY; SWITZ.; DA. 1972; VOL. 7; NO 4; PP. 259-263; BIBL. 11REF.Serial Issue

A NEW PSILOCYBIAN SPECIES OF COPELANDIAWEEKS RA; SINGER R; HEARN WL et al.1979; J. NAT. PROD.; USA; DA. 1979; VOL. 42; NO 5; PP. 469-474; BIBL. 23 REF.Article

HYPERSENSITIVITY TO LYSERGIC ACID DIETHYLAMIDE (LSD-25) AND PSILOCYBIN IN ESSENTIAL HEADACHE = HYPERSENSIBILITE AU DIETHYLAMIDE DE L'ACIDE LYSERGIQUE (LSD-25) ET A LA PSILOCYBINE DANS LA MIGRAINEFANCIULLACCI M; FRANCHI G; SICUTERI F et al.1974; EXPERIENTIA; SUISSE; DA. 1974; VOL. 30; NO 12; PP. 1441-1443; ABS. ITAL.; BIBL. 16 REF.Article

VASOCONSTRICTION PRODUCED BY HALLUCINOGENS ON ISOLATED HUMAN AND SHEEP UMBILICAL VASCULATURE = LA VASOCONSTRICTION PRODUITE PAR LES HALLUCINOGENES SUR LES VAISSEAUX OMBILICAUX ISOLES DE L'HOMME ET DU MOUTONDYER DC; GANT DW.1973; J. PHARMACOL. EXPER. THERAPEUT.; U.S.A.; DA. 1973; VOL. 184; NO 2; PP. 366-375; BIBL. 24 REF.Serial Issue